AstraZeneca

It is an outrage that the countries with the least resources are being charged the most in the midst of a global health emergency.

In response to the news that the Oxford University vaccine shows 70% protection, Heidi Chow, pharmaceuticals campaigner at Global Justice Now said: 
  
“These results are good news, but with so much government funding for this vaccine, it is time Oxford University’s deal with pharma giant AstraZeneca was made public. Individual parts have been leaked to the media, but the deal itself has been kept secret, so we don’t know the legal framework for making the vaccine available to the world.  
 

Patient groups have joined with campaigners to ask AstraZeneca for full disclosure of their plans to develop a coronavirus vaccine with Oxford University, outlining the need for vaccines to be patent-free. [1] 

The British pharmaceutical company has recently signed a deal with Oxford University to produce the vaccine and has already received orders from the UK and US governments. [2]

Subscribe to RSS - AstraZeneca

Latest posts

There are currently no published blog posts available.

Resources

There are currently no published resources available.

Latest news

It is an outrage that the countries with the least resources are being charged the most in the midst of a global health emergency.

In response to the news that the Oxford University vaccine shows 70% protection, Heidi Chow, pharmaceuticals campaigner at Global Justice Now said: 
  
“These results are good news, but with so much government funding for this vaccine, it is time Oxford University’s deal with pharma giant AstraZeneca was made public. Individual parts have been leaked to the media, but the deal itself has been kept secret, so we don’t know the legal framework for making the vaccine available to the world.  
 

Patient groups have joined with campaigners to ask AstraZeneca for full disclosure of their plans to develop a coronavirus vaccine with Oxford University, outlining the need for vaccines to be patent-free. [1] 

The British pharmaceutical company has recently signed a deal with Oxford University to produce the vaccine and has already received orders from the UK and US governments. [2]